Clinical trial
S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By…
NCT00492856 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00492856 |
|---|---|
| Title | S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia |
| Official title | S0521, A Randomized Trial of Maintenance Versus Observation for Patients With Previously Untreated Low and Intermediate Risk Acute Promyelocytic Leukemia (APL), Phase III |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | mercaptopurine, methotrexate, tretinoin |
| Enrollment | 105 |
| Start date | Jun 1, 2007 |
| Primary completion | Dec 1, 2013 |
| Completion | May 4, 2016 |
| First posted | Jun 27, 2007 |
| Last update posted | Jan 10, 2023 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: